Striatal Neurons in Multiple System Atrophy

Striatal Neurons in Multiple System Atrophy

Introduction

Striatal [Neurons](/entities/neurons) In Multiple System Atrophy is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-cell-type"> [@jellinger2014]
<table> [@fanciulli2015]
<tr><th>Cell Type</th><td>Striatal Neurons</td></tr> [@koga2022]
<tr><th>Disease</th><td>Multiple System Atrophy (MSA)</td></tr> [@gilman1999]
<tr><th>Region</th><td>Basal Ganglia / Striatum</td></tr>
<tr><th>Neurotransmitter</th><td>GABA + Dopamine</td></tr>
<tr><th>Classification</th><td>Medium Spiny Neurons, Interneurons</td></tr>
</table>
</div>

Overview

Striatal Neurons in Multiple System Atrophy

Introduction

Striatal [Neurons](/entities/neurons) In Multiple System Atrophy is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-cell-type"> [@jellinger2014]
<table> [@fanciulli2015]
<tr><th>Cell Type</th><td>Striatal Neurons</td></tr> [@koga2022]
<tr><th>Disease</th><td>Multiple System Atrophy (MSA)</td></tr> [@gilman1999]
<tr><th>Region</th><td>Basal Ganglia / Striatum</td></tr>
<tr><th>Neurotransmitter</th><td>GABA + Dopamine</td></tr>
<tr><th>Classification</th><td>Medium Spiny Neurons, Interneurons</td></tr>
</table>
</div>

Overview

The striatum is the primary input nucleus of the basal ganglia, comprising the caudate nucleus and putamen. In multiple system atrophy (MSA), a sporadic neurodegenerative disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia, striatal neurons undergo significant degeneration. This contributes to the prominent parkinsonian features that distinguish MSA from other parkinsonian disorders.

Neuroanatomy and Normal Function

Striatal Composition

The striatum contains several neuronal populations:

• Direct pathway (D1 receptor-expressing): Facilitate movement
• Indirect pathway (D2 receptor-expressing): Inhibit movement

• Cholinergic interneurons (tonically active neurons, TANs)
• GABAergic interneurons (fast-spiking, somatostatin+, NPY+)
• Parvalbumin+ interneurons

Normal Function

Striatal neurons:

Pathological Changes in MSA

Alpha-Synuclein Pathology

MSA is classified as a synucleinopathy with:

Striatal-Specific Pathology

Neurotransmitter Changes

• Dopamine depletion: Marked reduction in striatal dopamine and metabolites
• GABA alterations: Impaired GABAergic transmission
• [Acetylcholine](/entities/acetylcholine): Cholinergic dysfunction contributes to cognitive issues
• Glutamate: Altered excitatory neurotransmission

Clinical Manifestations

MSA-C vs MSA-P

MSA presents in two major variants:

• More prominent involvement of cerebellar pathways
• Less severe striatal pathology

• More severe striatal and nigral degeneration
• Less cerebellar involvement

Motor Symptoms from Striatal Degeneration

• Poor levodopa response (unlike PD)
• Early postural instability

• Dystonia (often axial or orofacial)
• Myoclonus
• Dysarthria (hypokinetic, ataxic, or spastic)

Autonomic Dysfunction

Striatal involvement contributes to:

• Orthostatic hypotension
• Urinary dysfunction
• Sexual dysfunction
• Gastrointestinal issues

Therapeutic Implications

Current Management

• Dopaminergic agents: Modest benefit in MSA-P
• Midodrine/fludrocortisone for orthostatic hypotension
• Anticholinergics for urinary urgency

• Physical therapy
• Speech therapy
• Occupational therapy

Emerging Approaches

• Alpha-synuclein targeting: Antibodies, aggregation inhibitors
• Myelin protection: Oligodendrocyte-supportive strategies
• Neurotrophic factors

Background

The study of Striatal Neurons In Multiple System Atrophy has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Cross-References

• [Multiple System Atrophy](/diseases/multiple-system-atrophy)
• [Medium Spiny Neurons](/cell-types/medium-spiny-neurons)
• [Oligodendrocytes in MSA](/cell-types/multiple-system-atrophy-oligodendrocytes)
• [Basal Ganglia Circuit](/mechanisms/basal-ganglia-circuit)
• [Alpha-Synuclein Pathology](/mechanisms/alpha-synuclein-pathology)
• [Parkinsonism Plus Syndromes](/diseases/parkinsonism-plus)

Brain Atlas Resources

• [Allen Cell Type Atlas](https://portal.brain-map.org/atlases-and-data/rnaseq) - Single-cell RNA sequencing data
• [Allen Brain Atlas](https://brain-map.org/) - Gene expression data

External Links

-